ES465059A1 - Production of specific immune nucleic acids cell dialysates and antibodies - Google Patents
Production of specific immune nucleic acids cell dialysates and antibodiesInfo
- Publication number
- ES465059A1 ES465059A1 ES465059A ES465059A ES465059A1 ES 465059 A1 ES465059 A1 ES 465059A1 ES 465059 A ES465059 A ES 465059A ES 465059 A ES465059 A ES 465059A ES 465059 A1 ES465059 A1 ES 465059A1
- Authority
- ES
- Spain
- Prior art keywords
- nucleic acids
- specific
- specific immune
- dialysates
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Gamma-globulins and immune nucleic acids, both specific to a given antigen, are produced by culturing in vitro an inducible cell line in the presence of specific immune nucleic acids or specific immune dialysates obtained either from human or animal donor lymphoid cells sensitized to said specific antigen or from cells of a previously induced cell line sensitized to said specific antigen, or in the presence of the liquid phase of a culture of a previously induced cell line sensitized to said specific antigen and extracting gamma-globulins from the liquid phase of the thus induced cell culture and/or extracting the immune nucleic acids from the cells so cultured. Specific immune dialysates may also be produced by a similar process.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB52674/76A GB1594097A (en) | 1976-12-16 | 1976-12-16 | Production of specific immune nucleic acids cell dialysates and antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
ES465059A1 true ES465059A1 (en) | 1978-09-01 |
Family
ID=10464835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES465059A Expired ES465059A1 (en) | 1976-12-16 | 1977-12-14 | Production of specific immune nucleic acids cell dialysates and antibodies |
Country Status (14)
Country | Link |
---|---|
US (1) | US4224404A (en) |
JP (1) | JPS5375321A (en) |
AU (1) | AU3151977A (en) |
BE (1) | BE861857A (en) |
CA (1) | CA1110988A (en) |
DK (1) | DK557477A (en) |
ES (1) | ES465059A1 (en) |
FI (1) | FI773784A (en) |
FR (1) | FR2374330A1 (en) |
GB (1) | GB1594097A (en) |
IE (1) | IE46215B1 (en) |
LU (1) | LU78690A1 (en) |
NL (1) | NL7713832A (en) |
NO (1) | NO774311L (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0091760B1 (en) * | 1982-04-09 | 1986-07-02 | FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. | Anti immune complex antibody and preparation thereof |
DE3245665A1 (en) * | 1982-05-04 | 1983-11-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | METHOD FOR PRODUCING PERMANENT ANIMAL AND HUMAN CELL LINES AND THE USE THEREOF |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4851510A (en) * | 1984-11-30 | 1989-07-25 | Wadley Technologies, Inc. | Monoclonal antibodies to novel melanoma-associated antigens |
US5192553A (en) | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
US5004681B1 (en) * | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
DE69032284T2 (en) * | 1989-03-21 | 1998-10-08 | Vical, Inc., San Diego, Calif. | EXPRESSION OF EXOGENOUS POLYNUCLEOTIDE SEQUENCES IN VERTEBLE |
US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
US6867195B1 (en) * | 1989-03-21 | 2005-03-15 | Vical Incorporated | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected |
US5693622A (en) * | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
US6214804B1 (en) | 1989-03-21 | 2001-04-10 | Vical Incorporated | Induction of a protective immune response in a mammal by injecting a DNA sequence |
US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
DE69031951T2 (en) * | 1989-11-16 | 1998-08-13 | Cornell Res Foundation Inc | Transformation of animal skin cells with the help of particles |
US6706694B1 (en) | 1990-03-21 | 2004-03-16 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate |
US20030186913A1 (en) * | 1990-03-21 | 2003-10-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate |
US6228844B1 (en) | 1991-11-12 | 2001-05-08 | Vical Incorporated | Stimulating vascular growth by administration of DNA sequences encoding VEGF |
US7001759B1 (en) | 1993-01-26 | 2006-02-21 | The Trustees Of The University Of Pennsylvania | Compositions and methods for delivery of genetic material |
US5981505A (en) * | 1993-01-26 | 1999-11-09 | The Trustees Of The University Of Pennsylvania | Compositions and methods for delivery of genetic material |
US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
AU675702B2 (en) * | 1993-01-26 | 1997-02-13 | Leslie R. Coney | Compositions and methods for delivery of genetic material |
US20040087521A1 (en) * | 1993-03-18 | 2004-05-06 | Merck & Co., Inc. | Nucleic acid pharmaceuticals-influenza matrix |
EP1624068A1 (en) | 1993-06-01 | 2006-02-08 | Life Technologies Inc. | Genetic immunization with cationic lipids |
US6348449B1 (en) | 1993-09-21 | 2002-02-19 | The Trustees Of The University Of Pennsylvania | Methods of inducing mucosal immunity |
IL112820A0 (en) * | 1994-03-07 | 1995-05-26 | Merck & Co Inc | Coordinate in vivo gene expression |
US6995008B1 (en) | 1994-03-07 | 2006-02-07 | Merck & Co., Inc. | Coordinate in vivo gene expression |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1617545C2 (en) | 1967-06-19 | 1983-11-03 | Diether Prof. Dr. Bern Jachertz | Use of informational ribonucleic acid as a vaccine |
GB1443948A (en) | 1972-10-20 | 1976-07-28 | Piktor Ltd | Production of immunological material |
-
1976
- 1976-12-16 GB GB52674/76A patent/GB1594097A/en not_active Expired
-
1977
- 1977-12-14 DK DK557477A patent/DK557477A/en unknown
- 1977-12-14 US US05/860,451 patent/US4224404A/en not_active Expired - Lifetime
- 1977-12-14 NL NL7713832A patent/NL7713832A/en not_active Application Discontinuation
- 1977-12-14 NO NO774311A patent/NO774311L/en unknown
- 1977-12-14 AU AU31519/77A patent/AU3151977A/en active Pending
- 1977-12-14 ES ES465059A patent/ES465059A1/en not_active Expired
- 1977-12-14 BE BE183460A patent/BE861857A/en unknown
- 1977-12-14 LU LU7778690A patent/LU78690A1/xx unknown
- 1977-12-14 FR FR7737742A patent/FR2374330A1/en active Granted
- 1977-12-14 IE IE2535/77A patent/IE46215B1/en unknown
- 1977-12-14 FI FI773784A patent/FI773784A/en not_active Application Discontinuation
- 1977-12-14 CA CA293,032A patent/CA1110988A/en not_active Expired
- 1977-12-14 JP JP15040677A patent/JPS5375321A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
FI773784A (en) | 1978-06-17 |
IE46215B1 (en) | 1983-04-06 |
LU78690A1 (en) | 1979-02-02 |
GB1594097A (en) | 1981-07-30 |
BE861857A (en) | 1978-06-14 |
NO774311L (en) | 1978-06-19 |
JPS5375321A (en) | 1978-07-04 |
NL7713832A (en) | 1978-06-20 |
IE46215L (en) | 1978-06-16 |
AU3151977A (en) | 1979-06-21 |
FR2374330B3 (en) | 1981-02-06 |
FR2374330A1 (en) | 1978-07-13 |
US4224404A (en) | 1980-09-23 |
CA1110988A (en) | 1981-10-20 |
DK557477A (en) | 1978-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES465059A1 (en) | Production of specific immune nucleic acids cell dialysates and antibodies | |
JPS5673029A (en) | Production of antibody against hepatitis virus and cell system therefor | |
ATE2965T1 (en) | CELL LINES, METHODS FOR THEIR PRODUCTION AND METHODS FOR PRODUCTION OF ANTIBODIES. | |
GB2000186A (en) | Method of producing antibodies in vitro | |
NL300020I1 (en) | Production of virus antigens. | |
MY106561A (en) | Method of making factor-dependent human b cell lines | |
ES480474A1 (en) | A serological method for determining the presence of Neisseria gonorrhoeae antibodies in human serum, a species-specific heat stable antigen to be used in this method and a method for the preparation of that antigen. | |
ES8106552A1 (en) | Process for propagating human hepatitis A virus in in vitro cell culture. | |
ES8104405A1 (en) | Influenza virus vaccines, process for preparing them and process for propagating influenza viruses. | |
PT72301B (en) | Process for the detection of human cancer cells with antibodies to human cancer nucleolar antigens | |
NZ183731A (en) | Process for culturing cells(microorganism and tissue culture) dependent on the relationship between cycle time and biomass efficiency ratio | |
IE44448L (en) | Gonococcal pili. | |
GB1443948A (en) | Production of immunological material | |
US4017361A (en) | Process for obtaining continuous lines of tumoral cells in vitro | |
KR850006705A (en) | Method for producing anti-tetanus antibody-producing human-human hybridoma | |
ES486851A1 (en) | Process for the production of ursodesoxycholic acid | |
PT83368A (en) | Process for propagating microorganisms in vivo by using cell lines which lack human class ii histocompatibility antigens | |
ES438723A1 (en) | Method of cultivating single-cell food proteins by a fermentation process | |
GB1436323A (en) | Cell and virus culture systems | |
JPS5254019A (en) | Method of making biological preparations | |
ES405090A1 (en) | Preparation of citric acid | |
KR890701631A (en) | Human Monoclonal Antibodies Against Aspergillus | |
JPS5329991A (en) | Production of vegetable cells in low concentration medium | |
GB2016044B (en) | Pretreatment of microcarriers for cell culture | |
ES407704A1 (en) | Procedure for the obtaining of proteins from ethanol synthesis. (Machine-translation by Google Translate, not legally binding) |